ES2182827T3 - Gen del virus corona canino y usos del mismo. - Google Patents

Gen del virus corona canino y usos del mismo.

Info

Publication number
ES2182827T3
ES2182827T3 ES93911346T ES93911346T ES2182827T3 ES 2182827 T3 ES2182827 T3 ES 2182827T3 ES 93911346 T ES93911346 T ES 93911346T ES 93911346 T ES93911346 T ES 93911346T ES 2182827 T3 ES2182827 T3 ES 2182827T3
Authority
ES
Spain
Prior art keywords
gene
same
crown virus
canine
canine crown
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93911346T
Other languages
English (en)
Spanish (es)
Inventor
Timothy J Miller
Sharon Klepfer
Albert Paul Reed
Elaine V Jones
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Application granted granted Critical
Publication of ES2182827T3 publication Critical patent/ES2182827T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ES93911346T 1992-05-08 1993-05-07 Gen del virus corona canino y usos del mismo. Expired - Lifetime ES2182827T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US88019492A 1992-05-08 1992-05-08

Publications (1)

Publication Number Publication Date
ES2182827T3 true ES2182827T3 (es) 2003-03-16

Family

ID=25375695

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93911346T Expired - Lifetime ES2182827T3 (es) 1992-05-08 1993-05-07 Gen del virus corona canino y usos del mismo.

Country Status (10)

Country Link
EP (1) EP0640098B1 (da)
JP (1) JP3245169B2 (da)
AT (1) ATE225805T1 (da)
AU (1) AU670092B2 (da)
CA (1) CA2135200C (da)
DE (1) DE69332375T2 (da)
DK (1) DK0640098T3 (da)
ES (1) ES2182827T3 (da)
PT (1) PT640098E (da)
WO (1) WO1993023423A1 (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU678970B2 (en) * 1992-05-08 1997-06-19 Pfizer Inc. Universal coronavirus vaccine
GB2282601B (en) * 1993-09-16 1998-04-15 Solvay Antigenically-active proteins/polypeptides and coronavirus vaccines containing the same
FR2828405B1 (fr) 2001-08-09 2005-06-24 Virbac Sa Vaccin anti-coronavirus
GB0217434D0 (en) 2002-07-27 2002-09-04 Royal Vetinary College Biological material
GB0315323D0 (en) 2003-07-01 2003-08-06 Royal Veterinary College Vaccine composition
US9023366B2 (en) 2003-07-01 2015-05-05 The Royal Veterinary College Vaccine composition for vaccinating dogs against canine infectious respiratory disease (CIRD)
CN113583096B (zh) * 2020-05-01 2023-06-30 清华大学 SARS-CoV-2 Spike蛋白受体结合域二聚体及其应用
CN112079906B (zh) * 2020-07-15 2022-11-04 张影 一种新型冠状病毒刺突蛋白、相关生物材料及其应用、检测试纸和检测试剂盒
CN113945714B (zh) * 2020-07-16 2023-01-31 南京蓬勃生物科技有限公司 新型冠状病毒中和抗体类药物中和能力的检测方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63123385A (ja) * 1986-09-05 1988-05-27 デュファル・インテルナチオナル・レセールフ・ベー・ヴェー 新規抗原的活性蛋白質およびぺプチド、並びにネコ科感染性腹膜炎ウイルスワクチン
HUT45559A (en) * 1987-01-16 1988-07-28 Duphar Int Res Process for producing new proteines and peptides of antigene activity and vaccines against virus of infective gastritis-enteritis
US4904468A (en) * 1987-06-08 1990-02-27 Norden Laboratories, Inc. Canine coronavirus vaccine
CA2005291C (en) * 1988-12-30 1999-01-26 Beverly Dale Feline infectious peritonitis virus diagnostic tools
ATE256746T1 (de) * 1991-04-25 2004-01-15 Akzo Nobel Nv Subeinheits-impfstoff gegen hundecoronavirus
EP0524672A1 (en) * 1991-06-27 1993-01-27 Duphar International Research B.V CCV vaccine
AU678970B2 (en) * 1992-05-08 1997-06-19 Pfizer Inc. Universal coronavirus vaccine

Also Published As

Publication number Publication date
WO1993023423A1 (en) 1993-11-25
ATE225805T1 (de) 2002-10-15
CA2135200A1 (en) 1993-11-25
DE69332375D1 (de) 2002-11-14
DE69332375T2 (de) 2003-02-13
AU670092B2 (en) 1996-07-04
EP0640098A1 (en) 1995-03-01
JPH07508421A (ja) 1995-09-21
CA2135200C (en) 2001-03-27
JP3245169B2 (ja) 2002-01-07
AU4251593A (en) 1993-12-13
EP0640098B1 (en) 2002-10-09
PT640098E (pt) 2003-01-31
EP0640098A4 (en) 1997-01-02
DK0640098T3 (da) 2002-10-28

Similar Documents

Publication Publication Date Title
ES2167717T3 (es) Nuevos aminoacidos ciclicos sustituidos como agentes farmaceuticos.
DE69536039D1 (de) Wirtszelle enthaltend ein rekombinantes Virus, welches ein Antigen exprimiert und ein rekombinantes Virus, welches ein immunstimulatorisches Molekül exprimiert
DE69519521D1 (de) Zusammensetzung enthaltend ein antigen exprimierendes rekombinantes virus und ein immunstimulierendes molekül exprimierendes rekombinantes virus
ES2150496T3 (es) Cicloalquilimidazopiridinas condensadas.
ES2143507T3 (es) Vacunas contra la enfermedad de aujeszky y de otras enfermedades animales que contienen mutantes del virus de la pseudorrabia.
BR0305426A (pt) Compostos inibidores de ns5b polimerase de hcv, bem como composição farmacêutica compreendendo os mesmos
ATE114169T1 (de) Morphogenetisches knochenprotein.
GT199900150A (es) 1,2,3,4-tetrahidroquinolinas 2-sustituidas 4-carboxiamino sustituidas.
BR0311126A (pt) Composições e método para tratar infecção em gado bovino e em suìnos
DE59204623D1 (de) Lagerstabile, permanent wasserbenetzbare vulkanisate ergebende polysiloxanmasse.
UY28084A1 (es) Derivados antivirales de nucleosidos
DE60327786D1 (de) Kdr-peptide und diese enthaltende impfstoffe
BR9812339A (pt) Processo para branquear os dentes, e, composição de higiene oral para branqueamento do dente
BR0312276A (pt) Mimeticorpos ch1-removidos miméticos de epo de mamìfero, composições, métodos e usos
MX9203379A (es) Proteinas producidas por los linfocitos humanos, secuencia de adn que codifica para estas proteinas y composiciones farmaceuticas que las contienen.
BR0305258A (pt) Inibidores de polimerase de ns5b de hcv
MX9305269A (es) Utilizacion del receptor de il-4 para la terapia,la profilaxis y el diagnostico de enfermedades alergicas, viricas, parasitarias y bacterianas asi como de infecciones por hongos.
BR0112540A (pt) Peptìdios como inibidores da ns-3-serina protease do vìrus da hepatite c
ATE118352T1 (de) Erreger der mysteriösen schweinekrankheit,impfstoff-zusammensetzungen und diagnose kits.
ES2103928T3 (es) Polipeptidos de mycobacterium y acidos nucleicos que los codifican utilizados en el diagnostico y el tratamiento de la tuberculosis.
ES2061520T3 (es) Expresion de un antigeno especifico de tumor por un virus vector recombinante y utilizacion de este para el tratamiento preventivo o curativo del tumor correspondiente.
ES2182827T3 (es) Gen del virus corona canino y usos del mismo.
PA8446301A1 (es) 2-amino-6-(4-fenoxi-2-sustituido)-piridinas sustituidas
ES2151506T3 (es) Moleculas de adn recombinante que codifican enzimas aminopeptidasa y su uso en la preparacion de vacunas contra infecciones por helmintos.
ATE264913T1 (de) Protease-resistente analoge des thrombomodulin